Related Experiment Video
Updated: Jun 28, 2026
07:11
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
15.5K
Peritoneal dialysis for refractory heart failure: A single-center experience
Dilek Aslan Kutsal1, Özlem Yıldırımtürk2, Aylin Sungur3
1Department of Nephrology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Summary
Peritoneal dialysis (PD) offers a viable treatment for refractory heart failure (HF) by reducing fluid overload. This approach significantly improved patient functional class and decreased hospitalizations.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Heart failure (HF) significantly impacts patient quality of life.
- Fluid overload is a common complication in refractory HF.
- Peritoneal dialysis (PD) presents a potential therapeutic option for managing fluid overload in HF patients.
Purpose of the Study:
- To evaluate the efficacy of PD in patients with refractory congestive heart failure.
- To assess the impact of PD on functional status and hospitalization rates in this patient population.
Main Methods:
- An observational study was conducted involving 10 patients with refractory congestive HF.
- PD was initiated primarily for the management of fluid overload.
- Baseline clinical parameters were compared with follow-up data.
Main Results:
- Patients had a median age of 57.5 years with significantly impaired left ventricular ejection fraction (20%) and right ventricular dysfunction.
- Peritoneal dialysis led to a significant reduction in New York Heart Association (NYHA) functional class from a median of 4 to 1 within 12 months.
- Hospitalizations decreased significantly in both number (median 3 to 0) and duration (median 50.5 to 0 days) post-PD initiation.
Conclusions:
- Peritoneal dialysis is an effective treatment for refractory heart failure, significantly improving NYHA functional class.
- PD therapy substantially reduces the frequency and length of hospitalizations in patients with refractory HF.
- Peritoneal dialysis can be considered a reasonable therapeutic option for the chronic management of refractory heart failure.
Related Concept Videos
01:27Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...